A prospective cohort study evaluating the impact of upscheduling codeine in Australia among frequent users of codeine.

Re-scheduling codeine in Australia has been accompanied by significant reductions in codeine use and prevalence rates of opioid use disorder in a cohort of individuals who regularly use the medication, without apparent adverse impacts on pain or measures of anxiety and depression.